BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34491231)

  • 1. Solving the Puzzle: The Diagnosis of Atypical Chronic Myeloid Leukemia, BCR-ABL1-Negative (aCML).
    Danyal K; Devitt K; Gardner JA
    J Assoc Genet Technol; 2021; 47(3):127-131. PubMed ID: 34491231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trametinib: Could It Be a Promising Drug to Treat Atypical Chronic Myeloid Leukemia?
    Elsayed M; Harry S; Nanua S; Zaidi S; Habib MH; Raza S
    Cureus; 2022 Jul; 14(7):e26619. PubMed ID: 35949766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical chronic myeloid leukaemia - a rare subtype of myelodysplastic/myeloproliferative neoplasm.
    Drozd-Sokołowska JE; Waszczuk-Gajda A; Mądry K; Dwilewicz-Trojaczek J
    Contemp Oncol (Pozn); 2018; 22(1):14-19. PubMed ID: 29692658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical chronic myeloid leukemia BCR-ABL 1 negative: A case report and literature review.
    Belkhair J; Raissi A; Elyahyaoui H; Ameur MA; Chakour M
    Leuk Res Rep; 2019; 12():100172. PubMed ID: 31194134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing atypical chronic myeloid leukemia from other Philadelphia-negative chronic myeloproliferative neoplasms.
    Sadigh S; Hasserjian RP; Hobbs G
    Curr Opin Hematol; 2020 Mar; 27(2):122-127. PubMed ID: 31904665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and evolving understanding of atypical chronic myeloid leukemia.
    Schwartz LC; Mascarenhas J
    Blood Rev; 2019 Jan; 33():74-81. PubMed ID: 30078497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical Chronic Myeloid Leukemia: Where Are We Now?
    Crisà E; Nicolosi M; Ferri V; Favini C; Gaidano G; Patriarca A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical chronic myeloid leukaemia with trisomy 13: a case report.
    Guo-yu H; Chao-hui Y; Kui T; Zhen-zhen C
    Chin Med Sci J; 2011 Dec; 26(4):254-6. PubMed ID: 22218057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical Chronic Myeloid Leukemia: New Developments from Molecular Diagnosis to Treatment.
    Castellino A; Santambrogio E; Rapezzi D; Massaia M
    Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical Chronic Myelogenous Leukemia,
    Diamantopoulos PT; Viniou NA
    Front Oncol; 2021; 11():722507. PubMed ID: 34868917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How I treat atypical chronic myeloid leukemia.
    Gotlib J
    Blood; 2017 Feb; 129(7):838-845. PubMed ID: 27899359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical Chronic Myeloid Leukemia in Two Pediatric Patients.
    Freedman JL; Desai AV; Bailey LC; Aplenc R; Burnworth B; Zehentner BK; Teachey DT; Wertheim G
    Pediatr Blood Cancer; 2016 Jan; 63(1):156-9. PubMed ID: 26274939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rare atypical chronic myeloid leukemia BCR-ABL1 negative with concomitant
    Gao T; Yu C; Xia S; Liang T; Gu X; Liu Z
    Ther Adv Hematol; 2020; 11():2040620720927105. PubMed ID: 32782768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: A retrospective nationwide study in Japan.
    Itonaga H; Ota S; Ikeda T; Taji H; Amano I; Hasegawa Y; Ichinohe T; Fukuda T; Atsuta Y; Tanizawa A; Kondo T; Miyazaki Y
    Leuk Res; 2018 Dec; 75():50-57. PubMed ID: 30458320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelodysplastic syndrome transforming to atypical chronic myeloid leukemia shows changes in its mutation allele frequency and acquisition of new mutations.
    Nm H; W T; A P; V T; A O
    Leuk Res Rep; 2021; 15():100248. PubMed ID: 34123720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, in a 5-Month Baby - ARare Presentation.
    Saqlain N; Ahmed N
    J Coll Physicians Surg Pak; 2016 Nov; 26(11):103-105. PubMed ID: 28666496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
    Hall J; Foucar K
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decitabine combined with CAG for the treatment of atypical chronic myeloid leukemia: a case report and literature review.
    Cheng J; Zhang H; Ma HZ
    Transl Cancer Res; 2020 Aug; 9(8):5015-5019. PubMed ID: 35117864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm.
    Fend F; Horn T; Koch I; Vela T; Orazi A
    Leuk Res; 2008 Dec; 32(12):1931-5. PubMed ID: 18555525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare e13a3 (b2a3) BCR-ABL1 fusion transcript with normal karyotype in chronic myeloid leukemia: The challenges in diagnosis and monitoring minimal residual disease (MRD).
    Duan MH; Li H; Cai H
    Leuk Res; 2017 Aug; 59():8-11. PubMed ID: 28527402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.